We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
IQVIA
IQV
$38.3B
| $33.4M | 0.08% |
212,200
+8,400
| +4% | +$1.32M |
|
252
ChargePoint
CHPT
$152M
| $33.4M | 0.08% |
107,047
-12,953
| -11% | -$2.82M |
|
253
MSCI
MSCI
$41.2B
| $33.3M | 0.08% |
93,400
-4,800
| -5% | -$1.74M |
|
|
BMY.RT
254
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $33.3M | 0.08% |
14,800,000
+1,084,159
| +8% | +$3.1M |
|
255
Synopsys
SNPS
$77.7B
| $33.1M | 0.08% |
154,900
-17,100
| -10% | -$3.48M |
|
256
Marathon Petroleum
MPC
$84B
| $33M | 0.08% |
1,125,710
+176,400
| +19% | +$6.2M |
|
|
TXNM
257
TXNM Energy Inc
TXNM
$5.92B
| $32.9M | 0.08% |
796,344
-250,000
| -24% | -$10.4M |
|
258
Corteva
CTVA
$51.3B
| $32.7M | 0.08% |
1,135,237
+296,380
| +35% | +$8.34M |
|
259
PACCAR
PCAR
$69.5B
| $32.6M | 0.08% |
573,663
+126,370
| +28% | +$7.09M |
|
260
KLA
KLAC
$252B
| $32.3M | 0.08% |
1,665,700
-378,000
| -18% | -$7.47M |
|
|
FLIR
261
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $32.1M | 0.08% |
896,312
+698,214
| +352% | +$26.6M |
|
262
MetLife
MET
$63.7B
| $32.1M | 0.08% |
863,326
+17,000
| +2% | +$645K |
|
263
Jazz Pharmaceuticals
JAZZ
$16.7B
| $32.1M | 0.08% |
225,000
| – | – |
|
264
F5
FFIV
$23.5B
| $32M | 0.08% |
260,600
+67,200
| +35% | +$9.04M |
|
265
Applied Materials
AMAT
$419B
| $31.7M | 0.08% |
533,926
-10,376
| -2% | -$641K |
|
|
ANSS
266
DELISTED
Ansys
ANSS
| $31.5M | 0.08% |
96,400
-3,100
| -3% | -$971K |
|
267
Voya Financial
VOYA
$9.2B
| $31.2M | 0.08% |
650,200
+400,000
| +160% | +$19.7M |
|
268
Semtech
SMTC
$12.6B
| $31.1M | 0.08% |
588,127
+156,000
| +36% | +$8.77M |
|
269
Adient
ADNT
$1.45B
| $31M | 0.08% |
1,787,531
+336,479
| +23% | +$5.86M |
|
|
WPX
270
DELISTED
WPX Energy, Inc.
WPX
| $31M | 0.08% |
6,321,800
-1,400,000
| -18% | -$7.75M |
|
271
Public Service Enterprise Group
PEG
$37.4B
| $30.9M | 0.08% |
562,984
-1,203,200
| -68% | -$63.7M |
|
272
Yum! Brands
YUM
$41.6B
| $30.6M | 0.08% |
334,891
-10,900
| -3% | -$1M |
|
|
XEC
273
DELISTED
CIMAREX ENERGY CO
XEC
| $30.4M | 0.08% |
1,250,309
+369,654
| +42% | +$9.73M |
|
274
Celldex Therapeutics
CLDX
$3.26B
| $30.4M | 0.08% |
2,050,000
+300,000
| +17% | +$3.51M |
|
275
Visteon
VC
$2.75B
| $30.1M | 0.08% |
435,497
-56,665
| -12% | -$4.19M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.